Cardiovascular Risk Factor Reduction in First Responders Resulting From an Individualized Lifestyle and Blood Test Program: A Randomized Controlled Trial.

Objective: We tested the hypothesis that a lifestyle program would improve risk factors linked to cardiovascular disease (CVD) in first responders. Methods: A 1-year cluster-randomized controlled clinical trial in 10 cities. Participants were 175 first responders, with increased waist circumference...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Occupational & Environmental Medicine Vol. 61; no. 3; pp. 183 - 190
Autores principales: Gill, Rosalynn, Superko, Harold Robert, McCarthy, Megan M., Jack, Kepra, Jones, Briana, Ghosh, Debanjali, Richards, Steve, Gleason, Joi A., Williams, Paul T., Dansinger, Michael
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Lippincott Williams & Wilkins Mar2019
Acceso en línea:Ver este registro en EBSCOhost
Descripción
Sumario:Objective: We tested the hypothesis that a lifestyle program would improve risk factors linked to cardiovascular disease (CVD) in first responders. Methods: A 1-year cluster-randomized controlled clinical trial in 10 cities. Participants were 175 first responders, with increased waist circumference and/or low levels of large (α1) high-density lipoprotein (HDL) particles. The intervention group received personalized online tools and access to telephonic coaching sessions. Results: At 1 year the intervention significantly reduced body weight (P = 0.004) and waist circumference (P = 0.002), increased α1 HDL (P = 0.01), and decreased triglyceride (P = 0.005) and insulin concentrations (P = 0.03). Program adherence was associated with weight loss (P = 0.0005) and increases in α1 HDL (P = 0.03). Conclusions: In first responders, a personalized lifestyle intervention significantly improved CVD risk factors in proportion to program adherence. Changes in large HDL particles were more sensitive indicators of lifestyle changes than HDL-cholesterol measurement. Clinical Trial Registration Number: ClinicalTrials.gov: NCT03322046